Global Organ Preservation and Perfusion Solution Market Research Report 2024
Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical
Publisher : MRA | Format : PDF
Global Organ Preservation and Perfusion Solution Market Research Report 2024
Organ preservation and perfusion solutions are specialized solutions used to maintain the viability and function of organs during transplantation or storage for medical purposes. These solutions are designed to provide optimal conditions for the preservation and transportation of organs from the donor to the recipient, ensuring minimal damage and maximizing the chances of a successful transplant.
According to MRAResearch’s new survey, global Organ Preservation and Perfusion Solution market is projected to reach US$ million in 2033, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2033. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Organ Preservation and Perfusion Solution market research.
Key companies engaged in the Organ Preservation and Perfusion Solution industry include 21st Century Medicine, Bridge to Life Limited, BioLife Solutions, Dr. Franz Köhler Chemie GmbH, XVIVO Perfusion, Artivion, Preservation Solutions, Bristol Myers Squibb and Teva Pharmaceuticals, etc. Among those companies, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % value of Organ Preservation and Perfusion Solution were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Organ Preservation and Perfusion Solution market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Organ Preservation and Perfusion Solution market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
21st Century Medicine
Bridge to Life Limited
BioLife Solutions
Dr. Franz Köhler Chemie GmbH
XVIVO Perfusion
Artivion
Preservation Solutions
Bristol Myers Squibb
Teva Pharmaceuticals
Lifeline Scientific
Advanced Life Solutions
Organ Recovery Systems
Transmedics
Accord Healthcare
Segment by Type
Static Cold Storage (SCS)
Hypothermic Perfusion Preservation (HPP)
Hypothermic Machine Preservation (HMP)
Others
Kidney
Liver
Heart
Lung
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Organ Preservation and Perfusion Solution report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source
According to MRAResearch’s new survey, global Organ Preservation and Perfusion Solution market is projected to reach US$ million in 2033, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2033. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Organ Preservation and Perfusion Solution market research.
Key companies engaged in the Organ Preservation and Perfusion Solution industry include 21st Century Medicine, Bridge to Life Limited, BioLife Solutions, Dr. Franz Köhler Chemie GmbH, XVIVO Perfusion, Artivion, Preservation Solutions, Bristol Myers Squibb and Teva Pharmaceuticals, etc. Among those companies, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % value of Organ Preservation and Perfusion Solution were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Organ Preservation and Perfusion Solution market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Organ Preservation and Perfusion Solution market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
21st Century Medicine
Bridge to Life Limited
BioLife Solutions
Dr. Franz Köhler Chemie GmbH
XVIVO Perfusion
Artivion
Preservation Solutions
Bristol Myers Squibb
Teva Pharmaceuticals
Lifeline Scientific
Advanced Life Solutions
Organ Recovery Systems
Transmedics
Accord Healthcare
Segment by Type
Static Cold Storage (SCS)
Hypothermic Perfusion Preservation (HPP)
Hypothermic Machine Preservation (HMP)
Others
Segment by Application
Kidney
Liver
Heart
Lung
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Organ Preservation and Perfusion Solution report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source